TCR: A Transformer Based Deep Network for Predicting Cancer Drugs Response
暂无分享,去创建一个
Fan Wang | Jie Gao | Xiaomin Fang | Yili Shen | Jing Hu | Wan-Na Sun | Xiaonan Zhang | Guo-Guo Zhao
[1] B. Schwikowski,et al. An overview of machine learning methods for monotherapy drug response prediction , 2021, Briefings Bioinform..
[2] Jike Wang,et al. Deep learning approaches for de novo drug design: An overview. , 2021, Current opinion in structural biology.
[3] J. Nemunaitis,et al. Ovarian Cancer Immunotherapy and Personalized Medicine , 2021, International journal of molecular sciences.
[4] Dilin Wang,et al. AttentiveNAS: Improving Neural Architecture Search via Attentive Sampling , 2020, 2021 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR).
[5] Stephen Lin,et al. Swin Transformer: Hierarchical Vision Transformer using Shifted Windows , 2021, 2021 IEEE/CVF International Conference on Computer Vision (ICCV).
[6] Rui Jiang,et al. DeepCDR: a hybrid graph convolutional network for predicting cancer drug response , 2020, bioRxiv.
[7] Subhabrata Mukherjee,et al. Uncertainty-aware Self-training for Few-shot Text Classification , 2020, NeurIPS.
[8] Mark Chen,et al. Language Models are Few-Shot Learners , 2020, NeurIPS.
[9] Nicolas Usunier,et al. End-to-End Object Detection with Transformers , 2020, ECCV.
[10] Jinyu Yu,et al. Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma , 2020, bioRxiv.
[11] Thin Nguyen,et al. Graph convolutional networks for drug response prediction , 2020, bioRxiv.
[12] L. G. Alexopoulos,et al. DeepSIBA: Chemical Structure-based Inference of Biological Alterations , 2020, Molecular omics.
[13] E. Robert McDonald,et al. Quantitative Proteomics of the Cancer Cell Line Encyclopedia , 2020, Cell.
[14] G. Schneider,et al. Rethinking drug design in the artificial intelligence era , 2019, Nature Reviews Drug Discovery.
[15] Kwong-Sak Leung,et al. Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network , 2018, BMC Bioinformatics.
[16] Jinyu Chen,et al. A Survey and Systematic Assessment of Computational Methods for Drug Response Prediction , 2019, bioRxiv.
[17] Yang Hua,et al. Ranked List Loss for Deep Metric Learning , 2019, 2019 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR).
[18] Evan Bolton,et al. PubChem 2019 update: improved access to chemical data , 2018, Nucleic Acids Res..
[19] Mehmet Tan,et al. Drug response prediction by ensemble learning and drug-induced gene expression signatures , 2018, Genomics.
[20] Joshua M. Korn,et al. Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.
[21] Ming-Wei Chang,et al. BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding , 2019, NAACL.
[22] Mohammad Rostami,et al. Discovering Molecular Functional Groups Using Graph Convolutional Neural Networks , 2018, ArXiv.
[23] Alán Aspuru-Guzik,et al. Inverse molecular design using machine learning: Generative models for matter engineering , 2018, Science.
[24] Mike Preuss,et al. Planning chemical syntheses with deep neural networks and symbolic AI , 2017, Nature.
[25] Olexandr Isayev,et al. Deep reinforcement learning for de novo drug design , 2017, Science Advances.
[26] Ranadip Pal,et al. Investigation of model stacking for drug sensitivity prediction , 2017, BMC Bioinformatics.
[27] Zhi Wei,et al. A link prediction approach to cancer drug sensitivity prediction , 2017, BMC Systems Biology.
[28] Lukasz Kaiser,et al. Attention is All you Need , 2017, NIPS.
[29] Max Welling,et al. Semi-Supervised Classification with Graph Convolutional Networks , 2016, ICLR.
[30] Francisco Azuaje,et al. Computational models for predicting drug responses in cancer research , 2016, Briefings Bioinform..
[31] Jin Gu,et al. Evaluating the molecule-based prediction of clinical drug responses in cancer , 2016, Bioinform..
[32] N. Cox,et al. Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models , 2016, Genome Biology.
[33] Emanuel J. V. Gonçalves,et al. A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.
[34] Abhinav Gupta,et al. Training Region-Based Object Detectors with Online Hard Example Mining , 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[35] E. V. Van Allen,et al. Next-generation sequencing to guide cancer therapy , 2015, Genome Medicine.
[36] Sergey Ioffe,et al. Batch Normalization: Accelerating Deep Network Training by Reducing Internal Covariate Shift , 2015, ICML.
[37] Jimmy Ba,et al. Adam: A Method for Stochastic Optimization , 2014, ICLR.
[38] R. Pal,et al. An Ensemble Based Top Performing Approach for NCI-DREAM Drug Sensitivity Prediction Challenge , 2014, PloS one.
[39] Nitish Srivastava,et al. Dropout: a simple way to prevent neural networks from overfitting , 2014, J. Mach. Learn. Res..
[40] N. Cox,et al. Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines , 2014, Genome Biology.
[41] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[42] Sridhar Ramaswamy,et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..
[43] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[44] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[45] A. Franke,et al. DNA methylome analysis using short bisulfite sequencing data , 2012, Nature Methods.
[46] Tie-Yan Liu,et al. Ranking Measures and Loss Functions in Learning to Rank , 2009, NIPS.
[47] Frederick P. Roth,et al. Chemical substructures that enrich for biological activity , 2008, Bioinform..
[48] Tie-Yan Liu,et al. Learning to rank: from pairwise approach to listwise approach , 2007, ICML '07.
[49] M. Stratton,et al. COSMIC 2005 , 2006, British Journal of Cancer.